The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
The federal agency announced Wednesday that it will review its "overpayment" process, after it was reported that it clawed back $4.7 billion of overpayments, while another $21.6 billion remains outstanding.
Even though six drug companies have filed lawsuits to halt the Medicare drug negotiation program, the companies have until Oct. 2 to present data on their drugs to CMS, which will make initial price offers in February.